Immune modulation after Toca 511 and Toca FC treatment of colorectal cancer patients.

Gerald Steven Falchook,Jordi Rodon Ahnert,Shree Venkat,Arthur Donahue,Peder Horner,Amber Thomassen,William Accomando,Maria Rodriguez-Aguirre,Cornelia Bentley,Daniel Hogan,Derek Ostertag,Sharon Yavrom,Thian Kheoh,Douglas J. Jolly,Harry E. Gruber,Jolene Shorr,Jaime R. Merchan

Immune modulation after Toca 511 and Toca FC treatment of colorectal cancer patients.

2020

Gerald Steven Falchook
Jordi Rodon Ahnert
Shree Venkat
Arthur Donahue
Peder Horner
Amber Thomassen
William Accomando
Maria Rodriguez-Aguirre
Cornelia Bentley
Daniel Hogan
Derek Ostertag
Sharon Yavrom
Thian Kheoh
Douglas J. Jolly
Harry E. Gruber
Jolene Shorr
Jaime R. Merchan

186Background: Toca 511 (vocimagene amiretrorepvec) is a cancer-selective, retroviral replicating vector encoding yeast cytosine deaminase that converts 5-fluorocytosine (5-FC) into 5-fluorouracil ...

Keywords:

Internal medicine
immune modulation
Medicine
Oncology
Colorectal cancer
Pathology
Cancer research
Yeast
Vocimagene Amiretrorepvec
Cytosine deaminase

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations